Overexpression of the cell surface receptor c‐erbB2 of the tyrosine kinase family, altered K‐ras oncogene, and irregularities in the FGFR2/ErbB3/PI3 kinase pathway have been widely related to GC (Zhu 2020). The gene discussed is FGFR2; the disease is gastric cancer.